Clinical Trial Update: A Phase 3 Study to Assess the Efficacy and Safety of PK101 in Patients With Knee Osteoarthritis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial assessing the efficacy and safety of PK101 in knee osteoarthritis is underway, with status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis

Drugs mentioned

• PK101

Snippet

Sponsor: PMG Pharm Co., Ltd | Conditions: Knee Osteoarthritis | Phase 3 | Status: UNKNOWN